Robotic Surgery Stocks
Discover investment opportunities in Robotic Surgery Stocks using our Smart AI Filter.
AI is processing your request...
AI is analyzing your request
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Robotic Surgery Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Robotic Surgery Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Robotic Surgery Stocks using our Smart AI Filter.
9 stocks found for "Robotic Surgery Stocks"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
---|---|---|---|---|---|---|
1.22 | ±57.6% | 16.6 | 0.00% | |||
0.55 | ±61.2% | -3.4 | 0.00% | |||
1.31 | ±100.0% | -15.8 | 0.00% | |||
0.83 | ±27.4% | 23.5 | 3.08% | |||
0.64 | ±28.2% | 69.3 | 0.00% | |||
0.89 | ±29.3% | 17.3 | 0.00% | |||
0.37 | ±19.7% | 14.7 | 3.18% | |||
0.70 | ±21.9% | 10.9 | 1.04% | |||
0.36 | ±21.7% | 15.1 | 3.17% |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Q: What drives investment interest in Intuitive Surgical (ISRG)?
A: Intuitive Surgical (ISRG) is a leader in robotic-assisted surgery systems, primarily the da Vinci Surgical System. The company's strong market position, consistent revenue growth, and innovation in minimally invasive surgery attract investor interest. This may suggest a competitive advantage in the growing robotic surgery market.
Q: How does Johnson & Johnson's (JNJ) involvement in robotic surgery influence its stock?
A: Johnson & Johnson (JNJ) entered the robotic surgery field through its subsidiary Ethicon, which has been developing the Ottava platform. This diversification into robotic surgery provides growth opportunities, although it's a fraction of JNJ’s broader healthcare operations. Investors often monitor its progression in this space for long-term potential.
Q: What are some potential risks associated with investing in TransEnterix (TRXC)?
A: TransEnterix (TRXC) focuses on digitizing the interface between the surgeon and patient, but it faces risks like competition from larger players, regulatory challenges, and the high cost of product development. These factors can influence its stock volatility and appeal to risk-tolerant investors.
Q: Why might Medtronic (MDT) be considered a stable investment in robotics?
A: Medtronic (MDT) is diversifying with its Hugo robotic-assisted surgery platform while having a solid base in medical devices. With a broad, established product portfolio, MDT offers stability amid innovation, appealing to investors interested in growth with relatively lower risk.
Q: How do Stryker's (SYK) robotic offerings impact its market position?
A: Stryker (SYK) enhances its orthopedic solutions with the Mako System, boosting its market position in joint replacement. Their focus on precision and improved surgical outcomes strengthens competitive positioning, potentially driving investor confidence in SYK's growth prospects in robotic surgery.
Q: What growth prospects does Globus Medical (GMED) offer in the context of robotic surgery?
A: Globus Medical (GMED) launched the ExcelsiusGPS, a robotic guidance and navigation system enhancing spinal surgeries. This innovation positions GMED for growth in the expanding robotic spine surgery market, appealing to investors keen on cutting-edge medical technologies.